Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Antengene Corporation Limited
  6. News
  7. Most relevant
    6996   KYG039571008

ANTENGENE CORPORATION LIMITED

(6996)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ANTENGENE CORPORATION LIMITED
10/15Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inh..
CI
10/05Antengene Corporation Limited commences an Equity Buyback Plan for 67,118,064 shares, r..
CI
10/03CORRECTION : Antengene to Repurchase Up to Nearly $13 Million Shares; Shares Rise 3%
MT
10/03ANTENGENE : to Repurchase Up to $5.1 Million Shares
MT
09/23Antengene Corporation Limited Reports Unaudited Consolidated Earnings Results for the S..
CI
09/15Antengene Selected as a Constituent of the FTSE Global Equity Index Series
DJ
09/03ANTENGENE : Cancer Treatment Gets Approval for Phase 1 Clinical Trial in Australia; Shares..
MT
08/23ANTENGENE : Gets Chinese Regulator Nod for Phase 2 Trial of Potential Myelofibrosis Treatm..
MT
08/23ANTENGENE : Announces Approval of the Phase II Study of Selinexor for the Treatment of Mye..
PR
08/23Antengene Corporation Limited Announces Approval of the Phase II Study of Selinexor for..
CI
08/23Antengene Narrows H1 Loss on Lower Research and Development Costs
MT
08/20Antengene Corporation Limited Announces Unaudited Consolidated Earnings Results for the..
CI
08/08Antengene Corporation Limited and MindRank AI Enter into Collaboration to Advance the D..
CI
08/02KARYOPHARM THERAPEUTICS : Partner Antengene Says Cancer Drug Xpovio Gets Approval in South..
MT
07/30ANTENGENE : Voluntary announcement approval of nda by the mfds for atg-010 (selinexor) for..
PU
07/30Antengene Corporation Limited Announces the Approval of NDA by the MFDS for ATG-010 for..
CI
07/26KARYOPHARM THERAPEUTICS : Says Selinexor Shows Potential Activity Against COVID-19 in Prec..
MT
07/21Antengene Announces The Approval by Human Research Ethics Committeein Australia and to ..
CI
07/13ANTENGENE : Submits New Drug Application for Selinexor in Taiwan for the Treatment of Thre..
PR
07/06Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Tr..
CI
07/05ANTENGENE : Announces Acceptance of IND Application in China for the Phase II Clinical Tri..
PR
06/21ANTENGENE CORPORATION LIMITED(SEHK : 6996) added to S&P Global BMI Index
CI
06/18Antengene Corporation Limited Announces Executive Changes
CI
06/11ANTENGENE : Founder And CEO Of Antengene, Dr. Jay Mei, Talks Innovation In Biotech, Passio..
AQ
06/04Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or ..
CI
05/28Antengene Corporation Limited Announces Board Changes
CI
05/28Antengene Corporation Limited Announces First Patient Dosed in Phase I/II Trial of Elta..
CI
05/25Antengene Corporation Limited Announces Appointment of Kathryn Gregory as Vice Presiden..
CI
05/20Certain Ordinary Shares of Antengene Corporation Limited are subject to a Lock-Up Agree..
CI
05/18ANTENGENE : Strikes Global Licensing Deal for Calithera Biosciences' Tumor Therapy; Shares..
MT
05/17EQS-NEWS : Antengene and Calithera Biosciences Enter into Worldwide Exclusive License Agre..
DJ
05/17CALITHERA BIOSCIENCES : Enters License Deal With Antengene for Development of Small Molecu..
MT
05/17Antengene Corporation Limited Announces the Completion of the Quantitative and Systems ..
CI
05/14ANTENGENE : Voluntary announcement nmpa approval of ind application for a phase ib/ii clin..
PU
05/14ANTENGENE : Wins Regulatory Nod to Start Phase Ib Trial of Tumor Therapy in China
MT
05/14Antengene Corporation Limited Announces the Completion of Its Manufacturing Center in S..
CI
05/14Antengene Corporation Limited Receives the Approval of the Investigational New Drug App..
CI
05/13ANTENGENE : Voluntary announcement nmpa approval of ind application for a phase iii clinic..
PU
05/13ANTENGENE : Wins Phase III Clinical Trial Nod in China for Cancer Drug
MT
05/12ANTENGENE : Announces IND Approval in China for a Global Phase III Trial of Selinexor in A..
PR
05/12Antengene Corporation Limited Announces IND Approval in China for a Global Phase III Tr..
CI
05/05ANTENGENE : Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelin..
PR
05/05Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guideli..
CI
05/04ANTENGENE : to Build Drug Manufacturing Center in China's Zhejiang Province
MT
05/03ANTENGENE : Voluntary announcement building of the drug discovery and manufacturing center..
PU
04/28EQS-NEWS : Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in t..
DJ
04/22ANTENGENE : Form of proxy for the 2020 annual general meeting
PU
04/13Antengene Presents Preclinical Data Demonstrating Potent Synergistic Effect of the Comb..
CI
04/12Antengene Corporation Limited Announces First Patient Dosed in Phase II Trial of ATG-00..
CI
04/06Antengene Wins Clinical Trial Nod in China for Lymphoma Drug
MT
04/06ANTENGENE : Voluntary announcement nmpa approval of ind application for atg-019 in patient..
PU
04/06Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advan..
CI
04/05ANTENGENE : Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanc..
PR
03/25ANTENGENE : Appoints Former Novartis Exec as Chief Medical Officer
MT
03/25ANTENGENE : Announces Financial Results for Full Year 2020
PR
03/25Antengene Appoints Kevin Lynch as Chief Medical Officer
CI
03/25ANTENGENE : Resignation and appointment of non-executive director
PU
03/25Antengene Corporation Limited Announces Board Changes
CI
03/25Antengene Corporation Limited Appoints Bo Shan as Chief Scientific Officer
CI
03/25Antengene Corporation Limited Reports Consolidated Earnings Results for the Year Ended ..
CI
03/21Antengene Corporation Limited Presents Preclinical Data Demonstrating the Synergistic E..
CI
03/15Antengene Appoints Minyoung Kim as General Manager of Antengene South Korea
CI
03/14ANTENGENE : Included in the Shenzhen-Hong Kong Stock Connect
PR
03/04ANTENGENE : Notice of date of board meeting
PU
02/28ANTENGENE : 6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexe..
PR
02/24Antengene Corporation Limited Announces NDA for ATG-010 Granted Priority Review by Chin..
CI
02/23ANTENGENE : Announces NDA for ATG-010 (Selinexor) Granted Priority Review by China's NMPA
PR
01/28ANTENGENE : Chinese Regulators Accept Antengene's Application for Myeloma Drug
MT
01/27Antengene Announces the Acceptance of ATG-010 NDA by the NMPA for the Treatment of rrMM
CI
01/25ANTENGENE : Global Trial of Lymphoma Drug Wins Regulatory Nod in China
MT
01/24Antengene Corporation Limited Announces Approval of IND Application in China for ATG-01..
CI
01/04Antengene Corporation Limited Announces Submission of IND Application in China for a Gl..
CI
01/03Antengene Corporation Limited Submits NDA for ATG-010 in South Korea for rrMM and rrDLB..
CI
2020ANTENGENE : US Watchdog Approves Drug for Multiple Myeloma By Antengene's Partner
MT
2020ANTENGENE : Chinese Regulator OKs Phase 3 Trial of Antengene's Drug for Relapsed/Refractor..
MT
1  2Next
Upcoming event on ANTENGENE CORPORATION LIMITED